$1.08
▼ $-0.05
(-4.42%)
Vol 269K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$26.9M
ROE
-47.5%
D/E
0.00
Beta
1.31
52W
$1–$3
Wall Street Consensus
7 analysts · Apr 20260
Strong Buy
0
Buy
4
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
PASG
Passage Bio Inc
$36.8M
AIXC
Aixcrypto Holdings Inc
$12.1M
LIXT
Lixte Biotechnology Holdings Inc
$31.5M
PSTV
Plus Therapeutics Inc
$70.4M
CYCN
Cyclerion Therapeutics Inc
$5.0M
NEUP
Neuphoria Therapeutics Inc
$20.9M
LGVN
Longeveron Inc
$10.8M
SKYE
Skye Bioscience Inc
$24.0M
VTGN
Vistagen Therapeutics Inc
$26.1M
Earnings
Beat rate: 40.0%
Next Report
May 07, 2026
EPS Estimate: $-0.59
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.59 | — | — |
| Dec 2025 | $-0.53 | $-0.58 | $-0.05 |
| Sep 2025 | $-0.59 | $-0.62 | $-0.03 |
| Jun 2025 | $-0.66 | $-0.70 | $-0.04 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$16.4M | -$15.8M | -$15.7M | -$13.9M | -$12.9M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -44.8% | -44.8% | -44.8% | -44.8% | -47.5% | -47.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 14.08 | 14.08 | 14.08 | 14.08 | 10.14 | 10.14 |
Key Ratios
ROA (TTM)
-33.1%
P/B
0.4
EPS (TTM)
$-16.06
52W High
$3.12
52W Low
$1.00
$1.00
52-Week Range
$3.12
Financial Health
Free Cash Flow
-$10.5M
Net Debt
$31.2M
Cash
$17.9M
Total Debt
$49.0M
As of Dec 31, 2025
How does BOLD compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BOLD valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.4
▼
83%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BOLD profitability vs Biotechnology peers
ROE
-47.5%
▲
29%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-33.1%
▲
29%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
BOLD financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
10.1
▲
128%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.3
▲
35%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
BOLD fundamentals radar
BOLD
Peer median
Industry
BOLD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BOLD vs peers: key metrics
Latest News
I'm Making a Bold Call on Texas Instruments Stock. Here's My Reasoning.
Yahoo Finance · Apr 03
Arm Is Making ‘Bold Moves’ with New In-House Chips and Wall Street …
Yahoo Finance · Apr 01
Bold Prediction: SMH Is About to Soar. Here's Why.
Nasdaq · Mar 22
Bold Prediction: Bitcoin Hits $100,000 Once Again by the End of 2026
Yahoo Finance · Mar 17